The global burden of Hepatitis A: Challenges, and future strategies

Hepatitis A, a positive-sense RNA virus, belongs to the Picornaviridae family that affects the liver and is transmitted via contaminated food and water. There are vaccines available that can effectively cure, but it is still a major health concern globally, specifically in areas with poor sanitation and low vaccination rates. In exploring HAV, it’s very important to understand the structure, its replication strategy, and transmission. The virus continues to affect communities globally, causing acute liver inflammation and leading to various clinical symptoms. This review focuses on how the virus operates, its epidemiology, and present methods for diagnosis and treatment. One of the focal points is the development of vaccines. Both Formalin-inactivated and live attenuated vaccines have promising results, and it is crucial to understand how our immune system responds to the infection. Additionally, socioeconomic factors play a significant role in how prevalent the disease is; limited access to healthcare can amplify the risk of transmission, especially in developing nations. Despite the availability of vaccines, there are significant hurdles to overcome. Vaccine hesitancy, where individuals are reluctant to get vaccinated, complicates efforts toward control and eradication. Additionally, unequal access to vaccines creates disparities that leave the most vulnerable populations at heightened risk. This situation is worsened by underdiagnosis, which means many cases go unrecognized and untreated, making it difficult to effectively monitor and intervene. To truly combat Hepatitis A and work toward its elimination, a comprehensive strategy is essential. We need to focus on increasing vaccination coverage, improving sanitation facilities, raising public awareness about prevention and treatment options, and investing in research for more effective vaccines. By tackling these interconnected issues, we can make significant strides in controlling and ultimately eradicating Hepatitis A around the world.